News - FDA Approves Abilify (Aripiprazole) for Treatment of Acute Bipolar Mania, Including Manic and Mixed Episodes

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Psychiatry Other

EXPLORE :

Most Read News

All News

All Webcasts / CME

All Cases

Congress Resource Centre

All Medical Resources

My Personal Edition

Warning | Privacy

Recent news - Psychiatry Other

	Asenapine, Olanzapine Effective in Patients With Bipolar 1 Disorder: Presented at WCBP - (DGDispatch)
	FDA: Boxed Warning Required for Varenicline, Buproprion Due to Risk of Suicidal Behaviour - (DGNews)
	Quetiapine Monotherapy Shows Potential in Post-Traumatic Stress Disorder: Presented at WCBP - (DGDispatch)
	Olanzapine Effective for Bipolar Disorder in Naturalistic Setting: Presented at WCBP - (DGDispatch)
	Study Suggests Irritability Should Be Considered When Diagnosing Bipolar Disorder in Children - (DGNews)

News archive

Recent webcasts/CME - Psychiatry Other

	A Guide to Advances in Pain Management: A Synopsis of Roundtable Discussions
	Recognizing and Managing Psychotic and Mood Disorders in Primary Care
	Challenges of the Comorbid Patient: Evaluating Common Comorbidities in Adults and Children/Adolescents and Treatment Considerations
	Mixed States: Practical Application of Evidence, Guidelines, and Clinical Judgment
	Hypomania: The Clinical Reality of Diagnosing Adult and Child/Adolescent Patients

Webcasts/CME archive

Recent cases - Psychiatry Other

	Female Sexual Dysfunction as a Comorbid Illness
	11p Microdeletion Including WT1 but not PAX6, Presenting with Cataract, Mental Retardation, Genital Abnormalities and Seizures: Case Report
	Comorbidity of Asperger's Syndrome and Bipolar Disorder
	Psychiatric Disorder Associated with Vacuum-Assisted Breast Biopsy Clip Placement: A Case Report
	Treating Bipolar Disorder in Patients with Renal Failure Having Haemodialysis: Two Case Reports

Cases archive

my personal edition > psychiatry other > news

E-Mail this DGNews to a colleague

DGNews

FDA Approves Abilify (Aripiprazole) for Treatment of Acute Bipolar Mania, Including Manic and Mixed Episodes

NEW YORK, NY -- October 4, 2004 -- The FDA has approved Abilify® (aripiprazole), for the treatment of acute bipolar mania, including manic and mixed episodes in patients with bipolar disorder.

More than 2 million Americans suffer from bipolar I disorder, a condition that causes extreme mood changes alternating between episodes of mania (highs), when the person's mood is elated and judgment impaired, and depression (lows), when the person may feel hopeless and believe they cannot be helped.

For bipolar I disorder, medicine plays a key role in helping manage symptoms. However, taking medicine as prescribed can be difficult. Because patients vary in their response to medication, it is important to have several treatment options available to help healthcare providers find an optimal treatment plan for each patient.

SOURCE: Bristol-Myers Squibb

E-Mail this DGNews to a colleague To print, use this version